simmitinib (SYHA1817) / CSPC Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
simmitinib (SYHA1817) / CSPC Pharma
NCT06132217: A Study of Simmitinib Plus SG001 in Advanced Solid Tumors

Not yet recruiting
1/2
168
RoW
Simmitinib, SG001
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Advanced Solid Tumor
01/27
01/27

Download Options